Eton Pharmaceuticals, Inc. (ETON) Gross margin 2019–2025
Eton Pharmaceuticals, Inc. (ETON) gross margin by fiscal year — reported gross profit divided by reported revenue.
53.5%FY2025 · since FY2019: 52.8% → 53.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 53.5% | -6.6 pp |
| FY2024 | 60.0% | -6.5 pp |
| FY2023 | 66.6% | -0.8 pp |
| FY2022 | 67.4% | -19.7 pp |
| FY2021 | 87.1% | +1105.0 pp |
| FY2020 | -1017.9% | -1070.7 pp |
| FY2019 | 52.8% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice